世界のEPA/DHA/ALA(オメガ3)市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP12012)
◆英語タイトル:Global EPA / DHA/ALA (Omega 3) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP12012
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月25日(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、EPA/DHA/ALA(オメガ3)の世界市場を広く調査・分析し、今後の市場展望をまとめております。EPA/DHA/ALA(オメガ3)の種類別市場規模(魚油、藻油)、用途別市場規模(栄養補助食品、機能性食品・飲料、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):EPAX、Polaris、Omega Protein、Golden Omega、GC Rieber、TASA、KD Pharma、Croda、Auqi
・地域別グローバル市場分析 2015年-2020年
・EPA/DHA/ALA(オメガ3)の北米市場(アメリカ、カナダ、メキシコ)
・EPA/DHA/ALA(オメガ3)のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・EPA/DHA/ALA(オメガ3)のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・EPA/DHA/ALA(オメガ3)の南米市場(ブラジル、アルゼンチン)
・EPA/DHA/ALA(オメガ3)の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:魚油、藻油
・用途別分析:栄養補助食品、機能性食品・飲料、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The EPA / DHA/ALA (Omega 3) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global EPA / DHA/ALA (Omega 3) sales will be xx in 2020 from EPA / DHA/ALA (Omega 3) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global EPA / DHA/ALA (Omega 3) market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the EPA / DHA/ALA (Omega 3) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on EPA / DHA/ALA (Omega 3) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
EPA / DHA/ALA (Omega 3) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, EPA / DHA/ALA (Omega 3) market has been segmented into
Fish Oil
Algae Oil

By Application, EPA / DHA/ALA (Omega 3) has been segmented into:
Dietary Supplements
Functional Foods & Beverages
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global EPA / DHA/ALA (Omega 3) market presented in the report. This section sheds light on the sales growth of different regional and country-level EPA / DHA/ALA (Omega 3) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global EPA / DHA/ALA (Omega 3) market.

The report offers in-depth assessment of the growth and other aspects of the EPA / DHA/ALA (Omega 3) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and EPA / DHA/ALA (Omega 3) Market Share Analysis
EPA / DHA/ALA (Omega 3) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, EPA / DHA/ALA (Omega 3) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the EPA / DHA/ALA (Omega 3) sales, revenue and market share for each player covered in this report.

The major players covered in EPA / DHA/ALA (Omega 3) are:
EPAX
Polaris
Omega Protein
Golden Omega
GC Rieber
TASA
KD Pharma
Croda
Auqi

Among other players domestic and global, EPA / DHA/ALA (Omega 3) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe EPA / DHA/ALA (Omega 3) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of EPA / DHA/ALA (Omega 3), with price, sales, revenue and global market share of EPA / DHA/ALA (Omega 3) in 2018 and 2019.
Chapter 3, the EPA / DHA/ALA (Omega 3) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the EPA / DHA/ALA (Omega 3) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, EPA / DHA/ALA (Omega 3) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe EPA / DHA/ALA (Omega 3) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 EPA / DHA/ALA (Omega 3) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global EPA / DHA/ALA (Omega 3) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Fish Oil
1.2.3 Algae Oil
1.3 Market Analysis by Application
1.3.1 Overview: Global EPA / DHA/ALA (Omega 3) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dietary Supplements
1.3.3 Functional Foods & Beverages
1.3.4 Others
1.4 Overview of Global EPA / DHA/ALA (Omega 3) Market
1.4.1 Global EPA / DHA/ALA (Omega 3) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: EPA / DHA/ALA (Omega 3) Industry Impact
1.6.1 COVID-19 Potential Implications for the EPA / DHA/ALA (Omega 3)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on EPA / DHA/ALA (Omega 3)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 EPAX
2.1.1 EPAX Details
2.1.2 EPAX Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 EPAX SWOT Analysis
2.1.4 EPAX Product and Services
2.1.5 EPAX EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Polaris
2.2.1 Polaris Details
2.2.2 Polaris Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Polaris SWOT Analysis
2.2.4 Polaris Product and Services
2.2.5 Polaris EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Omega Protein
2.3.1 Omega Protein Details
2.3.2 Omega Protein Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Omega Protein SWOT Analysis
2.3.4 Omega Protein Product and Services
2.3.5 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Golden Omega
2.4.1 Golden Omega Details
2.4.2 Golden Omega Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Golden Omega SWOT Analysis
2.4.4 Golden Omega Product and Services
2.4.5 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GC Rieber
2.5.1 GC Rieber Details
2.5.2 GC Rieber Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GC Rieber SWOT Analysis
2.5.4 GC Rieber Product and Services
2.5.5 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 TASA
2.6.1 TASA Details
2.6.2 TASA Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 TASA Product and Services
2.6.4 TASA EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 KD Pharma
2.7.1 KD Pharma Details
2.7.2 KD Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 KD Pharma Product and Services
2.7.4 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Croda
2.8.1 Croda Details
2.8.2 Croda Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Croda Product and Services
2.8.4 Croda EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Auqi
2.9.1 Auqi Details
2.9.2 Auqi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Auqi Product and Services
2.9.4 Auqi EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 EPA / DHA/ALA (Omega 3) Manufacturer Market Share in 2019
3.3.2 Top 6 EPA / DHA/ALA (Omega 3) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Regions
4.1.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Regions (2015-2020)
4.1.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Regions (2015-2020)
4.2 North America EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.3 Europe EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.5 South America EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
5.1.1 North America EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
5.1.2 North America EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
5.2 United States EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5.3 Canada EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5.4 Mexico EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
6.1.1 Europe EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
6.1.2 Europe EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
6.2 Germany EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.3 UK EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.4 France EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.5 Russia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.6 Italy EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue and Market Share by Regions (2015-2020)
7.2 China EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.3 Japan EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.4 Korea EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.5 India EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.7 Australia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
8.1.1 South America EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
8.1.2 South America EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
8.2 Brazil EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
8.3 Argentina EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.3 Turkey EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.4 Egypt EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.5 South Africa EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Type (2015-2020)
10.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Type (2015-2020)
10.3 Global EPA / DHA/ALA (Omega 3) Price by Type (2015-2020)
11 Global EPA / DHA/ALA (Omega 3) Market Segment by Application
11.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2015-2020)
11.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Application (2015-2020)
11.3 Global EPA / DHA/ALA (Omega 3) Price by Application (2015-2020)
12 Market Forecast
12.1 Global EPA / DHA/ALA (Omega 3) Sales, Revenue and Growth Rate (2021-2025)
12.2 EPA / DHA/ALA (Omega 3) Market Forecast by Regions (2021-2025)
12.2.1 North America EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.2 Europe EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.3 Asia-Pacific EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.4 South America EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.5 Middle East & Africa EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.3 EPA / DHA/ALA (Omega 3) Market Forecast by Type (2021-2025)
12.3.1 Global EPA / DHA/ALA (Omega 3) Sales Forecast by Type (2021-2025)
12.3.2 Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Type (2021-2025)
12.4 EPA / DHA/ALA (Omega 3) Market Forecast by Application (2021-2025)
12.4.1 Global EPA / DHA/ALA (Omega 3) Sales Forecast by Application (2021-2025)
12.4.2 Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

EPAX、Polaris、Omega Protein、Golden Omega、GC Rieber、TASA、KD Pharma、Croda、Auqi

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のEPA/DHA/ALA(オメガ3)市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global EPA / DHA/ALA (Omega 3) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。